Health Care & Life Sciences » Pharmaceuticals | Zhejiang Medicine Co. Ltd.

Zhejiang Medicine Co. Ltd. A | Cash Flow

Fiscal year is January-December. All values CNY Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
452,604.60
171,341.30
158,223.10
444,342.00
239,541.00
327,205.90
Depreciation, Depletion & Amortization
167,392.60
265,743.90
294,511.10
338,534.10
376,493.50
426,617
Other Funds
6,064.80
-
-
168,632.50
2,906.00
171,909.80
Funds from Operations
683,708.70
549,045.00
318,254.00
943,353.60
669,699.10
920,434.80
Changes in Working Capital
23,261.70
1,943.70
231,888.90
605,030.10
148,469.70
338,792.40
Net Operating Cash Flow
660,447.10
547,101.30
86,365.20
338,323.50
521,229.40
581,642.40
Capital Expenditures
1,187,462.20
991,756.40
724,963.20
381,764.80
569,986.70
Sale of Fixed Assets & Businesses
7,011.30
45,818.00
3,930.10
5,549.60
618,821.90
Purchase/Sale of Investments
24,000.00
5,538.70
264,965.90
250.00
281,225.60
Net Investing Cash Flow
1,180,674.30
914,079.30
447,997.20
400,835.00
232,390.40
Cash Dividends Paid - Total
260,030.00
140,416.20
56,166.50
46,805.40
139,540.50
Issuance/Reduction of Debt, Net
-
100,000.00
270,000.00
68,720.40
29,614.70
Net Financing Cash Flow
253,965.20
40,416.20
213,833.50
190,547.50
175,550.10
Net Change in Cash
793,761.10
428,045.90
115,313.40
162,677.60
97,108.60
Free Cash Flow
527,015.20
444,655.10
638,598.10
43,441.30
48,757.30
Deferred Taxes & Investment Tax Credit
1,564.50
9,051.80
1,065.00
6,569.00
38,652.40
5,297.90
Net Assets from Acquisitions
-
-
-
12,669.70
-
Other Sources
23,776.70
26,320.40
8,070.00
3,300.00
-
Change in Capital Stock
-
-
-
-
3,489.00
Exchange Rate Effect
19,568.70
20,651.60
32,485.10
34,641.60
16,180.30
Other Uses
-
-
-
15,000.00
-

About Zhejiang Medicine Co.

View Profile
Address
58 Changhe Road
Shaoxing Zhejiang 312366
China
Employees -
Website http://www.china-zmc.com
Updated 07/08/2019
Zhejiang Medicine Co., Ltd. engages in the production and sale of pharmaceutical products. It offers anti-infective drugs, glucosidase inhibitors, immunosuppressant, human nutrition, and animal nutrition drugs. The company was founded on May 16, 1997 and is headquartered in Shaoxing, China.